<DOC>
	<DOCNO>NCT02753777</DOCNO>
	<brief_summary>Pemphigus bullous pemphigoid ( BP ) severe autoimmune blistering disease ( AIBD ) pose critical need new therapeutic approach . Clinical trial pemphigus BP require availability validate disease severity measure use define primary outcome .</brief_summary>
	<brief_title>Autoimmune Blistering Diseases Study</brief_title>
	<detailed_description>The disease severity instrument pemphigus BP , Pemphigus Disease Area Index ( PDAI ) Bullous Pemphigoid Disease Area Index ( BPDAI ) , respectively , potential capture change grade disease activity , include mild disease , therefore represent substantial improvement simple lesion count measurement affect body surface area . However , full validation PDAI BPDAI use clinical trial require additional extensive measurement enable u classify patient correctly disease severity define minimal change score clinically significant . This database study compare Pemphigus Disease Area Severity Index ( PDAI ) Bullous Pemphigoid Disease Area Index ( BPDAI ) disease severity measure , include Autoimmune Bullous Skin Disorder Intensity Score ( ABSIS ) physician 's global assessment . Additionally , patient ask rate overall disease severity use visual analogue scale , patient 's global assessment . Participants also option donate blood sample AIBD blood bank immunologic pathophysiologic study . The purpose database study also evaluate quality life ( QoL ) measure correlate QoL measure disease severity patient pemphigus BP . QoL important independent component disease impact patient . This database study use follow QoL measure : SF-36 , nonspecific QoL measure ; Skindez-29 Dermatology Life Quality Index ( DLQI ) , dermatology-specific instrument ; Autoimmune Bullous Disease Quality Life ( ABQOL ) Treatment Autoimmune Bullous Disease Quality Life ( TABQOL ) questionnaires , AIBD-specific tool . The result utilize planning future clinical study . The AIBD study conduct Penn time . Data study enter password protect , web-based database use Penn .</detailed_description>
	<mesh_term>Pemphigus</mesh_term>
	<mesh_term>Pemphigoid , Bullous</mesh_term>
	<criteria>Gender/Age : Males females 18 year old Diagnosis : pemphigus vulgaris , pemphigus foliaceus , bullous pemphigoid Subjects able give inform consent Patients age 18 year . Patients without pemphigus pemphigoid diseases Penn employee Penn student Cognitively impaired person</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>